CCM
ELOS

Camber Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Camber Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,347,593
Closed -$25.7M – 38
2017
Q2 		$25.7M Hold
2,347,593
– – 1.25% 23
2017
Q1 		$24.8M Hold
2,347,593
– – 1% 24
2016
Q4 		$19.7M Hold
2,347,593
– – 1.03% 27
2016
Q3 		$16.8M Hold
2,347,593
– – 0.74% 27
2016
Q2 		$18.1M Buy
2,347,593
+841,893
+56% +$6M 0.87% 32
2016
Q1 		$11M Hold
1,505,700
– – 0.64% 35
2015
Q4 		$11.6M Buy
+1,505,700
New +$11.5M 0.75% 32

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Camber Capital Management's ELOS Position: Q3 2017 in Review

Camber Capital Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 2,347,593 shares — an estimated $25.7M sold.

Camber Capital Management first reported a position in ELOS in Q4 2015 and held it in 7 quarters. The position peaked at $25.7M in Q2 2017. 3 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Camber Capital Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Camber Capital Management sold 2,347,593 Syneron Medical Ltd shares in Q3 2017, an estimated $25.7M.
  • Camber Capital Management first reported a position in Syneron Medical Ltd in Q4 2015 and held it in 7 quarters.
  • Camber Capital Management's Syneron Medical Ltd position peaked at $25.7M in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Camber Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.